- Filed
- May 5, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 30, 2026 | 7.54M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 7.62M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 7.49M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $0 |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $201K |
| Capex | Q1 2026 · Mar 31, 2026 | $1.14M |
| Capex | Q1 2026 · Mar 31, 2025 | $701K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $1.89M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $1.23M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $113.79M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $114.28M |
| Long Term Debt | Q1 2026 · Mar 31, 2025 | $120.26M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $8.36M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $8.36M |
| Short Term Debt | Q1 2026 · Mar 31, 2025 | $8.36M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $1.67M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $2.9M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $2.56M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $252.54M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $252.09M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $236.21M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $232.22M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $91.93M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $96.13M |
| Current Liabilities | Q1 2026 · Mar 31, 2025 | $98.09M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $224.65M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $225.4M |
| Total Liabilities | Q1 2026 · Mar 31, 2025 | $232.01M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $266.76M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $270.72M |
| Current Assets | Q1 2026 · Mar 31, 2025 | $258.68M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $477.19M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $477.49M |
| Total Assets | Q1 2026 · Mar 31, 2025 | $468.22M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.17 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.66 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.17 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.66 |
| Net Income | Q1 2026 · Mar 31, 2026 | $1.26M |
| Net Income | Q1 2026 · Mar 31, 2025 | $4.94M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $3.64M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $8.71M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $45.43M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $47.01M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $78.97M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $67.07M |